DJIA 18,037.97 -42.17 -0.23%
NASDAQ 5,060.25 -31.84 -0.63%
S&P 500 2,108.92 -8.77 -0.41%
market minute promo

Prothena Corporation (NASDAQ: PRTA)

36.37 -0.98 (-2.62%)

REAL-TIME: Last trade at

Extended Hours: $36.37 $0.00 (0.00%)
Quote as of (NASDAQ)

company name or ticker

Recent Quotes

PRTA $36.37 -2.62%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $37.38
Previous Close $37.35
Daily Range $35.33 - $38.13
52-Week Range $16.71 - $45.00
Market Cap $996.5M
P/E Ratio -128.79
Dividend (Yield) $0.00 (0.0%)
Volume 584,660
Average Daily Volume 782,007
Current FY EPS -$2.59



Prothena Corporation (PRTA) Description

Prothena Corporation plc - Ordinary Shares Website:

News & Commentary Rss Feed

3 Little-Known Biotechs Working On Potential Blockbusters

These three biotechs have promising drugs in their pipelines that address billion dollar drug markets.

Prothena (PRTA) Stock Declines Today on Pricing of Secondary Offering

Heavy Early Morning Activity On Prothena (PRTA)

Too Many Secondaries In Biotech - Cramer's Lightning Round (4/6/15)

Can the Uptrend Continue for Prothena (PRTA)? - Tale of the Tape

The Zacks Analyst Blog Highlights: Biogen, Prothena, Vertex, Gilead and Amgen - Press Releases

This Tiny Biotech Offers Up New Hope for Parkinson's Disease Patients

Phase 1 trial results for Prothena Corporation's PRX-002 could indicate that this drug may help treat Parkinson's disease someday.

How Big Will The Biotech Bubble Get?

Prothena (PRTA) Is Today's Perilous Reversal Stock

Jim Cramer's Top Takeaways: Papa Murphy's, Nike, Prothena

See More PRTA News...